Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Solutech-TC10 Emulsion in Healthy Adults
NCT04601207Phase 1Completed
- Sponsor
- New Age Ventures
- Start
- Jun 2020
- Primary completion
- Nov 2020
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Solutech-TC10 (2 arms), sponsored by New Age Ventures. Primary endpoints: Area under the curve (AUC0-48h), Maximum concentration (Cmax, 0-48h) and 1 more. Started Jun 2020; status: completed.
02
Drugs
Solutech-TC10
Beyond the preview
Go deeper on NCT04601207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04601207.